NSE - Delayed Quote INR

Excel Industries Limited (EXCELINDUS.NS)

879.30 -21.75 (-2.41%)
At close: April 19 at 3:29 PM GMT+5:30
Loading Chart for EXCELINDUS.NS
DELL
  • Previous Close 901.05
  • Open 890.00
  • Bid --
  • Ask --
  • Day's Range 870.00 - 896.85
  • 52 Week Range 699.80 - 1,017.50
  • Volume 19,576
  • Avg. Volume 24,475
  • Market Cap (intraday) 11.053B
  • Beta (5Y Monthly) 0.71
  • PE Ratio (TTM) 88.46
  • EPS (TTM) 9.94
  • Earnings Date May 24, 2024
  • Forward Dividend & Yield 11.25 (1.28%)
  • Ex-Dividend Date Sep 7, 2023
  • 1y Target Est --

Excel Industries Limited manufactures and sells chemicals, pharma intermediates, and environmental and biotech products in India and internationally. The company provides agrochemical intermediate; industrial, specialty, and mining chemicals; pesticides intermediates; polymer additives; pharmaceuticals intermediates; and active pharma ingredients (APIs), as well as casscel, phosphorous derivatives, biocides, and phosphonates. It also offers organic waste management composting, municipal solid waste management, plastic waste management, and construction and demolition waste management. In addition, the company provides polymer input and specialty monomer; and veterinary APIs. Excel Industries Limited was founded in 1941 and is headquartered in Mumbai, India.

www.excelind.co.in

1,020

Full Time Employees

March 31

Fiscal Year Ends

Related News

Performance Overview: EXCELINDUS.NS

Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

EXCELINDUS.NS
3.16%
S&P BSE SENSEX
1.17%

1-Year Return

EXCELINDUS.NS
2.65%
S&P BSE SENSEX
22.37%

3-Year Return

EXCELINDUS.NS
12.21%
S&P BSE SENSEX
49.67%

5-Year Return

EXCELINDUS.NS
14.37%
S&P BSE SENSEX
86.73%

Compare To: EXCELINDUS.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EXCELINDUS.NS

Valuation Measures

As of 4/19/2024
  • Market Cap

    11.04B

  • Enterprise Value

    8.95B

  • Trailing P/E

    88.46

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.36

  • Price/Book (mrq)

    0.80

  • Enterprise Value/Revenue

    1.10

  • Enterprise Value/EBITDA

    17.36

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.53%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    8.19B

  • Net Income Avi to Common (ttm)

    124.99M

  • Diluted EPS (ttm)

    9.94

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.03B

  • Total Debt/Equity (mrq)

    0.13%

  • Levered Free Cash Flow (ttm)

    --

People Also Watch